Cargando…
Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study
Anecdotal evidence rapidly accumulated during March 2020 from sites around the world that sudden hyposmia and hypogeusia are significant symptoms associated with the SARS-CoV-2 pandemic. Our objective was to describe the prevalence of hyposmia and hypogeusia and compare it in hospitalized and non-ho...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543958/ https://www.ncbi.nlm.nih.gov/pubmed/33033955 http://dx.doi.org/10.1007/s10096-020-04056-7 |
_version_ | 1783591761497554944 |
---|---|
author | Nouchi, Agathe Chastang, Julie Miyara, Makoto Lejeune, Julie Soares, André Ibanez, Gladys Saadoun, David Morélot-Panzini, Capucine Similowski, Thomas Amoura, Zahir Boddaert, Jacques Caumes, Eric Bleibtreu, Alexandre Lorenzo, Alain Tubach, Florence Pourcher, Valérie |
author_facet | Nouchi, Agathe Chastang, Julie Miyara, Makoto Lejeune, Julie Soares, André Ibanez, Gladys Saadoun, David Morélot-Panzini, Capucine Similowski, Thomas Amoura, Zahir Boddaert, Jacques Caumes, Eric Bleibtreu, Alexandre Lorenzo, Alain Tubach, Florence Pourcher, Valérie |
author_sort | Nouchi, Agathe |
collection | PubMed |
description | Anecdotal evidence rapidly accumulated during March 2020 from sites around the world that sudden hyposmia and hypogeusia are significant symptoms associated with the SARS-CoV-2 pandemic. Our objective was to describe the prevalence of hyposmia and hypogeusia and compare it in hospitalized and non-hospitalized COVID-19 patients to evaluate an association of these symptoms with disease severity. We performed a cross-sectional survey during 5 consecutive days in March 2020, within a tertiary referral center, associated outpatient clinic, and two primary care outpatient facilities in Paris. All SARS-CoV-2-positive patients hospitalized during the study period and able to be interviewed (n = 198), hospital outpatients seen during the previous month (n = 129), and all COVID-19-highly suspect patients in two primary health centers (n = 63) were included. Hospitalized patients were significantly more often male (64 vs 40%) and older (66 vs 43 years old in median) and had significantly more comorbidities than outpatients. Hyposmia and hypogeusia were reported by 33% of patients and occurred significantly less frequently in hospitalized patients (12% and 13%, respectively) than in the health centers’ outpatients (33% and 43%, respectively) and in the hospital outpatients (65% and 60%, respectively). Hyposmia and hypogeusia appeared more frequently after other COVID-19 symptoms. Patients with hyposmia and/or hypogeusia were significantly younger and had significantly less respiratory severity criteria than patients without these symptoms. Olfactory and gustatory dysfunction occurs frequently in COVID-19, especially in young, non-severe patients. These symptoms might be a useful tool for initial diagnostic work-up in patients with suspected COVID-19. |
format | Online Article Text |
id | pubmed-7543958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-75439582020-10-09 Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study Nouchi, Agathe Chastang, Julie Miyara, Makoto Lejeune, Julie Soares, André Ibanez, Gladys Saadoun, David Morélot-Panzini, Capucine Similowski, Thomas Amoura, Zahir Boddaert, Jacques Caumes, Eric Bleibtreu, Alexandre Lorenzo, Alain Tubach, Florence Pourcher, Valérie Eur J Clin Microbiol Infect Dis Original Article Anecdotal evidence rapidly accumulated during March 2020 from sites around the world that sudden hyposmia and hypogeusia are significant symptoms associated with the SARS-CoV-2 pandemic. Our objective was to describe the prevalence of hyposmia and hypogeusia and compare it in hospitalized and non-hospitalized COVID-19 patients to evaluate an association of these symptoms with disease severity. We performed a cross-sectional survey during 5 consecutive days in March 2020, within a tertiary referral center, associated outpatient clinic, and two primary care outpatient facilities in Paris. All SARS-CoV-2-positive patients hospitalized during the study period and able to be interviewed (n = 198), hospital outpatients seen during the previous month (n = 129), and all COVID-19-highly suspect patients in two primary health centers (n = 63) were included. Hospitalized patients were significantly more often male (64 vs 40%) and older (66 vs 43 years old in median) and had significantly more comorbidities than outpatients. Hyposmia and hypogeusia were reported by 33% of patients and occurred significantly less frequently in hospitalized patients (12% and 13%, respectively) than in the health centers’ outpatients (33% and 43%, respectively) and in the hospital outpatients (65% and 60%, respectively). Hyposmia and hypogeusia appeared more frequently after other COVID-19 symptoms. Patients with hyposmia and/or hypogeusia were significantly younger and had significantly less respiratory severity criteria than patients without these symptoms. Olfactory and gustatory dysfunction occurs frequently in COVID-19, especially in young, non-severe patients. These symptoms might be a useful tool for initial diagnostic work-up in patients with suspected COVID-19. Springer Berlin Heidelberg 2020-10-08 2021 /pmc/articles/PMC7543958/ /pubmed/33033955 http://dx.doi.org/10.1007/s10096-020-04056-7 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Nouchi, Agathe Chastang, Julie Miyara, Makoto Lejeune, Julie Soares, André Ibanez, Gladys Saadoun, David Morélot-Panzini, Capucine Similowski, Thomas Amoura, Zahir Boddaert, Jacques Caumes, Eric Bleibtreu, Alexandre Lorenzo, Alain Tubach, Florence Pourcher, Valérie Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study |
title | Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study |
title_full | Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study |
title_fullStr | Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study |
title_full_unstemmed | Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study |
title_short | Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study |
title_sort | prevalence of hyposmia and hypogeusia in 390 covid-19 hospitalized patients and outpatients: a cross-sectional study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543958/ https://www.ncbi.nlm.nih.gov/pubmed/33033955 http://dx.doi.org/10.1007/s10096-020-04056-7 |
work_keys_str_mv | AT nouchiagathe prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT chastangjulie prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT miyaramakoto prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT lejeunejulie prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT soaresandre prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT ibanezgladys prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT saadoundavid prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT morelotpanzinicapucine prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT similowskithomas prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT amourazahir prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT boddaertjacques prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT caumeseric prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT bleibtreualexandre prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT lorenzoalain prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT tubachflorence prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy AT pourchervalerie prevalenceofhyposmiaandhypogeusiain390covid19hospitalizedpatientsandoutpatientsacrosssectionalstudy |